BrainCool AB is a medical device company engaged in developing, marketing, and selling medical cooling systems for diseases like stroke, oral mucositis, migraine, and sudden cardiac arrest.
2017
13
LTM Revenue $5.4M
LTM EBITDA -$3.1M
$38.6M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
BrainCool has a last 12-month revenue of $5.4M and a last 12-month EBITDA of -$3.1M.
In the most recent fiscal year, BrainCool achieved revenue of $4.2M and an EBITDA of -$4.1M.
BrainCool expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See BrainCool valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $2.4M | $4.2M | XXX | XXX | XXX |
Gross Profit | $1.4M | $1.3M | XXX | XXX | XXX |
Gross Margin | 57% | 30% | XXX | XXX | XXX |
EBITDA | -$5.9M | -$4.1M | XXX | XXX | XXX |
EBITDA Margin | -243% | -99% | XXX | XXX | XXX |
Net Profit | -$4.8M | -$6.4M | XXX | XXX | XXX |
Net Margin | -196% | -153% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 23, 2025, BrainCool's stock price is SEK 2 (or $0).
BrainCool has current market cap of SEK 385M (or $40.2M), and EV of SEK 369M (or $38.6M).
See BrainCool trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$38.6M | $40.2M | XXX | XXX | XXX | XXX | $-0.02 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 23, 2025, BrainCool has market cap of $40.2M and EV of $38.6M.
BrainCool's trades at 7.1x LTM EV/Revenue multiple, and -12.3x LTM EBITDA.
Analysts estimate BrainCool's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for BrainCool and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $38.6M | XXX | XXX | XXX |
EV/Revenue | 9.2x | XXX | XXX | XXX |
EV/EBITDA | -9.3x | XXX | XXX | XXX |
P/E | -8.7x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | -5.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialBrainCool's NTM/LTM revenue growth is 63%
BrainCool's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged n/a for the same period.
Over next 12 months, BrainCool's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate BrainCool's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for BrainCool and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 72% | XXX | XXX | XXX | XXX |
EBITDA Margin | N/A | XXX | XXX | XXX | XXX |
EBITDA Growth | -30% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 0% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
Opex per Employee | n/a | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 1% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
BrainCool acquired XXX companies to date.
Last acquisition by BrainCool was XXXXXXXX, XXXXX XXXXX XXXXXX . BrainCool acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was BrainCool founded? | BrainCool was founded in 2017. |
Where is BrainCool headquartered? | BrainCool is headquartered in Sweden. |
How many employees does BrainCool have? | As of today, BrainCool has 13 employees. |
Is BrainCool publicy listed? | Yes, BrainCool is a public company listed on STO. |
What is the stock symbol of BrainCool? | BrainCool trades under BRAIN ticker. |
When did BrainCool go public? | BrainCool went public in 2014. |
Who are competitors of BrainCool? | Similar companies to BrainCool include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
What is the current market cap of BrainCool? | BrainCool's current market cap is $40.2M |
What is the current revenue of BrainCool? | BrainCool's last 12-month revenue is $5.4M. |
What is the current EBITDA of BrainCool? | BrainCool's last 12-month EBITDA is -$3.1M. |
What is the current EV/Revenue multiple of BrainCool? | Current revenue multiple of BrainCool is 7.1x. |
What is the current EV/EBITDA multiple of BrainCool? | Current EBITDA multiple of BrainCool is -12.3x. |
What is the current revenue growth of BrainCool? | BrainCool revenue growth between 2023 and 2024 was 72%. |
Is BrainCool profitable? | Yes, BrainCool is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.